Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2011 (2011), Article ID 530568, 3 pages
http://dx.doi.org/10.1155/2011/530568
Case Report

Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report

1Rheumatology Unit, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo 71, 41100 Modena, Italy
2Microbiology and Virology Service, Policlinico di Modena, Via del Pozzo 71, 41100 Modena, Italy

Received 2 May 2011; Accepted 30 May 2011

Academic Editors: W. Chierakul, F. Mansour-Ghanaei, and C. G. Meyer

Copyright © 2011 Michele Colaci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.